# Pierre Amarenco

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pierre-amarenco/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,489 |
| Field | Acute Ischemic Stroke Management |
| h-index | 108 |
| i10-index | 345 |
| Last Known Institution | Université Claude Bernard Lyon 1 |
| OpenAlex ID | https://openalex.org/A5023091399 |
| ORCID iD | https://orcid.org/0000-0002-3842-1236 |
| Works | 648 |

## Researcher papers

- [Lipoprotein(a) as a cardiovascular risk factor: current status](https://scholariq.org/papers/lipoprotein-a-as-a-cardiovascular-risk-factor-current-status/)
- [Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management](https://scholariq.org/papers/triglyceride-rich-lipoproteins-and-high-density-lipoprotein-cholesterol-in/)
- [Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source](https://scholariq.org/papers/rivaroxaban-for-stroke-prevention-after-embolic-stroke-of-undetermined-source/)
- [HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials](https://scholariq.org/papers/hmg-coenzyme-a-reductase-inhibition-type-2-diabetes-and-bodyweight-evidence-from/)
- [Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events](https://scholariq.org/papers/very-low-levels-of-atherogenic-lipoproteins-and-the-risk-for-cardiovascular/)
- [Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study](https://scholariq.org/papers/hemorrhagic-stroke-in-the-stroke-prevention-by-aggressive-reduction-in/)
- [Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study](https://scholariq.org/papers/addition-of-brain-and-carotid-imaging-to-the-abcd2-score-to-identify-patients-at/)
- [Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial](https://scholariq.org/papers/prehospital-transdermal-glyceryl-trinitrate-in-patients-with-ultra-acute/)
- [Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data](https://scholariq.org/papers/intravenous-alteplase-for-stroke-with-unknown-time-of-onset-guided-by-advanced/)
- [Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial](https://scholariq.org/papers/rivaroxaban-or-aspirin-for-patent-foramen-ovale-and-embolic-stroke-of/)

## Researcher topics

- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [Lyon 1 Université](https://scholariq.org/institutions/lyon-1-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.